Development of Periodontitis after Antihelicobacter Therapy in Patients with Ulcer Disease

Authors

  • Shokhsanam Khurramova Junior Scientific Researcher, 2nd year student at Tashkent State Dental Institute, Tashkent, Uzbekistan
  • Bekhzod Abdullaev Scientific researcher, 5th year student of GP faculty, Tashkent Medical Academy, Tashkent, Uzbekistan

DOI:

https://doi.org/10.18488/journal.99/2017.4.1/99.1.1.7

Abstract

Helicobacter pylori infection is associated with the most common diseases of the stomach and duodenum such as peptic ulcer, gastric cancer, and chronic gastritis. Stomach and duodenum are well-conditioned organs for bacteria. Oral cavity is considered a secondary reservoir of H. pylori. The infection responds well to complex antibacterial treatment, but the risk of recurrence and side effects of this treatment is sufficiently high. This article discusses the H.pylori-related pathology of oral cavity and paradentium, and the side effects and tolerability of eradication therapy. The pathways for optimization of the treatment for H. pylori infection with the use of drugs contributing to the restoration of microflora of the gastrointestinal tract and oral cavity are offered.

Keywords:

Periodontitis, Helicobacter pylori, Ulcer disease, Quadrotherapy, Antimicrobial drugs

Abstract Video

Published

2017-01-19

How to Cite

Khurramova, S. ., & Abdullaev, B. . (2017). Development of Periodontitis after Antihelicobacter Therapy in Patients with Ulcer Disease. Journal of Diseases, 4(1), 1–7. https://doi.org/10.18488/journal.99/2017.4.1/99.1.1.7

Issue

Section

Articles